Delivery Order SPE2DB22D2206-SPE2DB25FJP62
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,331.84 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed price delivery order, with an ultimate completion date of August 7, 2025, represents a pediatric or maintenance supply requirement for this specialty cardiovascular medication used to treat high cholesterol. The contract was competitively awarded with no set-aside designation and will be performed...
- The Defense Logistics Agency awarded a $15,001.90 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $31,046.64 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. The award represents a pediatric or adult cardiovascular pharmaceutical supply supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on August 14, 2025, with a ceiling value of $1,041.42 and an ultimate completion date of August 15, 2025. This competitive, firm fixed-price delivery order represents pharmaceutical supply to support military and federal healthcare requirements. The award is classified as a child contract, indicating it derives from a larger contract vehicle. This delivery order...
- The Defense Logistics Agency awarded a $1,513.48 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a specialty pharmaceutical product for cholesterol management. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,562.13 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a pediatric or specialty pharmaceutical requirement fulfilled through AmerisourceBergen's established federal contract infrastructure. The award was made without a set-aside designation, indicating competitive...
- The Defense Logistics Agency awarded a delivery order valued at $1,203.06 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price contract, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance will occur at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, valued at $1,214.32 with a firm fixed price. The contract, which was competitively awarded without a set-aside designation, has an ultimate completion date of August 14, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is listed as the vendor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $4,540.44 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and was awarded without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a delivery order valued at $11,573.95 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designation. AmerisourceBergen, a major...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJP62Delivery Order
The Defense Logistics Agency awarded a $16,211.55 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric and adult cardiovascular pharmaceutical supply supporting federal medical procurement needs. The contract is issued without set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete openly for federal medical supply requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The company, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor with an extensive federal contract portfolio demonstrating consistent performance across multiple therapeutic domains and delivery requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 8/22/25 |